EP 2299976 A4 20140723 - CONTROLLED RELEASE AURIS SENSORY CELL MODULATOR COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS
Title (en)
CONTROLLED RELEASE AURIS SENSORY CELL MODULATOR COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS
Title (de)
OHRSENSORZELLENMODULIERENDE ZUSAMMENSETZUNGEN MIT GESTEUERTER FREISETZUNG UND VERFAHREN ZUR BEHANDLUNG VON OHRERKRANKUNGEN
Title (fr)
COMPOSITIONS DE MODULATEUR DE CELLULES SENSORIELLES AURICULAIRES À LIBÉRATION CONTRÔLÉE ET PROCÉDÉS DE TRAITEMENT DE TROUBLES OTIQUES
Publication
Application
Priority
- US 2009067552 W 20091210
- US 14003308 P 20081222
- US 16023309 P 20090313
- US 16481209 P 20090330
- GB 0907070 A 20090424
- US 17442109 P 20090430
- US 50455309 A 20090716
Abstract (en)
[origin: WO2010074992A2] Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with auris sensory cell modulating agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).
IPC 8 full level
A61K 9/06 (2006.01); A61K 9/127 (2006.01); A61K 9/16 (2006.01); A61K 31/045 (2006.01); A61K 47/34 (2006.01); A61K 47/38 (2006.01); A61P 27/16 (2006.01)
CPC (source: CN EP)
A61K 9/0046 (2013.01 - CN EP); A61K 9/006 (2013.01 - EP); A61K 9/06 (2013.01 - CN EP); A61K 9/127 (2013.01 - EP); A61K 31/00 (2013.01 - EP); A61K 31/4535 (2013.01 - CN); A61K 45/06 (2013.01 - EP); A61K 47/10 (2013.01 - CN EP); A61K 47/14 (2013.01 - EP); A61K 47/34 (2013.01 - EP); A61K 47/38 (2013.01 - EP); A61P 27/16 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
- [XI] WO 2007038949 A1 20070412 - AURIS MEDICAL AG [CH], et al
- [XPI] WO 2009139924 A2 20091119 - OTONOMY INC [US], et al
- [XP] WO 2009132050 A2 20091029 - OTONOMY INC [US], et al
- [Y] WO 0007603 A2 20000217 - MADASH LLP [US]
- [Y] US 2004101560 A1 20040527 - SAWCHUK RONALD J [US], et al
- [A] EP 0551626 A1 19930721 - LEK TOVARNA FARMACEVTSKIH [YU]
- See references of WO 2010074992A2
Citation (examination)
US 2007015727 A1 20070118 - PUEL JEAN-LUC [FR], et al
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
Designated extension state (EPC)
AL BA RS
DOCDB simple family (publication)
WO 2010074992 A2 20100701; WO 2010074992 A3 20101021; AU 2009330458 A1 20100701; AU 2009330458 B2 20130822; CA 2732686 A1 20100701; CA 2732686 C 20171003; CN 102112111 A 20110629; CN 106344495 A 20170125; EP 2299976 A2 20110330; EP 2299976 A4 20140723; JP 2012513394 A 20120614; JP 2015164943 A 20150917; JP 2017160232 A 20170914; JP 2018138585 A 20180906; JP 6013736 B2 20161025; JP 6207093 B2 20171004
DOCDB simple family (application)
US 2009067552 W 20091210; AU 2009330458 A 20091210; CA 2732686 A 20091210; CN 200980130562 A 20091210; CN 201610730867 A 20091210; EP 09835529 A 20091210; JP 2011542272 A 20091210; JP 2015095099 A 20150507; JP 2017087624 A 20170426; JP 2018083451 A 20180424